The Kidney: An important target for HIV infection

Area of Science:

• Nephrology
• Infectious Diseases
• Immunology

Background:

• Human Immunodeficiency Virus (HIV) infection is associated with diverse renal manifestations.
• Acute renal failure in HIV patients often stems from sepsis, hypotension, and nephrotoxic agents, and is potentially reversible.
• HIV-associated nephropathy (HIVAN) is a distinct sclerosing glomerulopathy affecting 1-10% of the HIV-infected population.

Purpose of the Study:

• To elucidate the pathogenic mechanisms of HIV-associated nephropathy, a rapidly progressive focal segmental glomerulosclerosis.
• To provide insights applicable to the treatment of idiopathic focal segmental glomerulosclerosis.
• To review advancements in improving renal survival for patients with HIVAN.

Main Methods:

• Review of existing literature on HIV-related renal diseases.
• Analysis of prevalence data for HIV-associated nephropathy across different regions.
• Examination of therapeutic strategies including antiretroviral therapy, immunosuppression, and ACE inhibition.

Main Results:

• Acute renal failure in HIV is often multifactorial and potentially manageable with supportive care.
• HIVAN presents a significant and growing global health challenge.
• Antiretroviral agents, immunosuppressive therapies, and ACE inhibitors show promise in enhancing renal outcomes for HIVAN patients.

Conclusions:

• Management of acute renal failure in HIV patients requires prompt identification and supportive care.
• Understanding HIVAN pathogenesis is crucial for developing targeted therapies.
• Multimodal treatment approaches, including antiretroviral therapy, are improving the prognosis for renal survival in HIV-infected individuals with nephropathy.